The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Mylan Inc

Nasdaq: MYL
Last

(U.S.) $57.60

Today's change+0.63 +1.11%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.
 

Mylan Inc

Nasdaq: MYL
Last

(U.S.) $57.60

Today's change+0.63 +1.11%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Mylan Inc up (U.S.)$0.63

Mylan Inc closed up Friday by (U.S.)$0.63 or 1.11% to (U.S.)$57.60. Over the last five days, shares are unchanged, but are currently 3.36% below its 52-week high. This security has outperformed the S&P 500 by 21.12% during the last year.

Key company metrics

  • Open(U.S.) $56.99
  • Previous close(U.S.) $56.97
  • High(U.S.) $57.72
  • Low(U.S.) $56.99
  • Bid / Ask-- / --
  • YTD % change+32.72%
  • Volume1,038,920
  • Average volume (10-day)2,967,573
  • Average volume (1-month)3,258,456
  • Average volume (3-month)4,080,630
  • 52-week range(U.S.) $41.97 to (U.S.) $59.60
  • Beta1.22
  • Trailing P/E24.85×
  • P/E 1 year forward16.18×
  • Forward PEG1.13×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.32
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.40%

Based on its net profit margin of 12.40%, Mylan Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue2,0841,8371,7161,809
Total other revenue--------
Total revenue2,0841,8371,7161,809
Gross profit1,024819748818
Total cost of revenue1,0601,019968990
Total operating expense1,5931,6121,4801,531
Selling / general / administrative379356335340
Research & development157139117130
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)77976071
Other operating expenses, total-80------
Operating income491226236278
Interest income (expense), net non-operating-92-93-91-84
Gain (loss) on sale of assets--------
Other--------
Income before tax413138152193
Income after tax499127117181
Income tax, total-87113512
Net income499125116180
Total adjustments to net income------0
Net income before extra. items499125116180
Minority interest0-1-1-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items499125116180
Inc. avail. to common incl. extra. items499125116180
Diluted net income499125116180
Dilution adjustment------0
Diluted weighted average shares397397397396
Diluted EPS excluding extraordinary itemsvalue per share1.260.320.290.45
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.380.540.400.62